As of 19 April 2022, 11:55 AM AEST, the benchmark index S&P/ASX 200 opens up higher by 54.80 points or 0.73% and currently trading at 7578.20 price levels. 8 out of 11 sectors are trading in a green zone along with the S&P/ASX 200. The Material and Energy sectors are the top 2 gaining sectors and gaining 1.43% and 1.26% in their index value. Information Technology and Healthcare sector are the top 2 loser stocks, declining 1.34% and 0.52% in their index value, respectively.
Imugene Limited (ASX: IMU) and Ramelius Resources Limited (ASX: RMS) are the top gaining stocks, gaining 4.651% and 4.318% in their stock prices. Paladin Energy Ltd (ASX: PDN) and Lynas Rare Earths Limited (ASX: LYC) are the top losing stocks and are declining 5.182% and 4.527% in their stock prices.
Factors Behind the rise-
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Suite 1A, Level 2, 802-808 Pacific Highway, Gordon NSW 2072, Australia | 1800 005 780 | info@kapitales.com.au
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
